NOVEL COMPOUNDS TARGETING SYNAPSIN III RESCUE ALPHA-SYNUCLEIN AGGREGATION AND NIGROSTRIATAL DYSFUNCTION AND DEGENERATION IN EXPERIMENTAL MODELS OF PARKINSON’S DISEASE
Main Authors: | Francesca Longhena, Gaia Faustini, Andrea Casiraghi, Valentina Straniero, Giovanni Ribaudo, Veronica Mutti, Gisela Camacho-Hernandez, Cristina Missale, Amy Hauck Newman, Federica Bono, Alessandra Gianoncelli, Ermanno Valoti, Arianna Bellucci |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | IBRO Neuroscience Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667242123009120 |
Similar Items
-
Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson’s Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice
by: Andrea Casiraghi, et al.
Published: (2022-07-01) -
Synapsin III Regulates Dopaminergic Neuron Development in Vertebrates
by: Gaia Faustini, et al.
Published: (2022-12-01) -
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
by: Viviana Brembati, et al.
Published: (2023-05-01) -
Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s Disease
by: Viviana Brembati, et al.
Published: (2023-08-01) -
Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family.
by: Anwar, S, et al.
Published: (2011)